A recombinant circumsporozoite protein vaccine against malaria
Brettler, D.B.
New England Journal of Medicine 336(24): 1759; Author Reply 1760-1761
1997
ISSN/ISBN: 0028-4793 PMID: 9182221 Document Number: 479067
Document emailed within 1 workday
Related Documents
Russo, D.M.; Sundy, J.S.; Young, J.F.; Maguire, H.C.; Weidanz, W.P. 1989: Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum Journal of Immunology 143(2): 655-659Wang, R.; Charoenvit, Y.; Corradin, G.; Porrozzi, R.; Hunter, R.L.; Glenn, G.; Alving, C.R.; Church, P.; Hoffman, S.L. 1995: Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine Journal of Immunology 155(3): 1637
Dale, J.B.; Chiang, E.Y.; Lederer, J.W. 1993: Recombinant tetravalent group A streptococcal M protein vaccine Journal of Immunology 151(4): 2188-2194
Dolo, A.; Modiano, D.; Doumbo, O.; Bosman, A.; Sidibé, T.; Keita, M.M.; Naitza, S.; Robson, K.J.; Crisanti, A. 1999: Thrombospondin related adhesive protein (TRAP), a potential malaria vaccine candidate Parassitologia 41(1-3): 425-428
Suwanabun, N.; Sattabongkot, J.; Wirtz, R.A.; Rosenberg, R. 1994: The epidemiology of Plasmodium vivax circumsporozoite protein polymorphs in Thailand American Journal of Tropical Medicine and Hygiene 50(4): 460-464
Herrera, S.; Escobar, P.; de Plata, C.; Avila, G.I.; Corradin, G.; Herrera, M.A. 1992: Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein Journal of Immunology 148(12): 3986-3990
Nosten, F.; Luxemburger, C.; Kyle, D.E.; Ballou, W.R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D.M.; White, N.J.; Sadoff, J.C.; Heppner, D.G. 1996: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group Lancet 348(9029): 701-707
Good, M.F.; Pombo, D.; Maloy, W.L.; de la Cruz, V.F.; Miller, L.H.; Berzofsky, J.A. 1988: Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein Journal of Immunology 140(5): 1645-1650
Gan, Y.; Shi, Y.-e.; Bu, L.-y.; Ning, C.-x.; Zhu, H.-g. 2005: Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica Zhonghua Yi Xue Za Zhi 85(3): 193-198
Kumkhaek, C.; Phra-ek, K.; Singhasivanon, P.; Looareesuwan, S.; Hirunpetcharat, C.; Brockman, A.; Grüner, A.Charlotte.; Lebrun, N.; Rénia, L.; Nosten, Fçois.; Snounou, G.; Khusmith, S. 2004: A survey of the Th2R and Th3R allelic variants in the circumsporozoite protein gene of P. falciparum parasites from western Thailand Southeast Asian Journal of Tropical Medicine and Public Health 35(2): 281-287
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Esposito, F.; Gambella, R.; Modiano, D.; Lamizana, L.; Lombardi, S.; Rotigliano, G.; Habluetzel, A. 1991: Waiting for the vaccine: sporozoite vaccine research entails important progress in malaria epidemiology Parassitologia 33(1): 85-91
Char, S.; Colston, M.J.; Mitchison, N.A.; Simon, K. 1990: Purification of recombinant Mycobacterium leprae 65-kilodalton antigen and murine antibody responses to intravenously administered recombinant protein Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 41(3): 336-338
Zhang, X.; Zhao, T.; Zeng, T.; Wu, N.; Xiao, Y.; Liu, S.; Yu, J.; Jiang, C.; Gan, L.; Deng, M.; Luo, X.; Zhao, F. 2018: Intramuscular primary immunization by nucleic acid vaccine pcDNA/Gpd-IL-2 and enhanced immunization with mucosal adjuvant CpG-ODN and Gpd-IL-2 recombinant protein effectively induced strong mucosal immune responses and immune protective effects against Treponema pallidum skin infection Experimental and Therapeutic Medicine 15(3): 2533-2540
Elghazali, G.; Esposito, F.; Troye-Blomberg, M. 1995: Comparison of the number of IL-4 and IFN-gamma secreting cells in response to the malaria vaccine candidate antigen Pf155/RESA in two groups of naturally primed individuals living in a malaria endemic area in Burkina Faso Scandinavian Journal of Immunology 42(1): 39-45
Chen, J-Ming.; Gao, C.; Shi, Q.; Gao, Y-Jun.; Lei, Y-Jun.; Shan, B.; Dong, C-Fang.; Wang, G-Rong.; Shi, S.; Han, J.; Dong, X-Ping. 2008: PrP protein can bind to protein kinase CK2 both in native and recombinant forms in vitro Bing du Xue Bao 24(5): 335-339
Songsivilai, S.; Dharakul, T.; Kunkitti, R.; Thepthai, C. 1996: Molecular cloning and expression of hepatitis C virus core protein and production of monoclonal antibodies to the recombinant protein Asian Pacific Journal of Allergy and Immunology 14(1): 31-41
Yoshio, T.; Masuyama, J.; Ikeda, M.; Tamai, K.; Hachiya, T.; Emori, T.; Mimori, A.; Takeda, A.; Minota, S.; Kano, S. 1995: Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus Journal of Rheumatology 22(9): 1681-1687
Curtiss, R.; Kelly, S.M.; Tinge, S.A.; Tacket, C.O.; Levine, M.M.; Srinivasan, J.; Koopman, M. 1994: Recombinant Salmonella vectors in vaccine development Developments in Biological Standardization 82: 23-33
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3